MOLINARI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 4.255
EU - Europa 2.625
AS - Asia 2.569
SA - Sud America 410
AF - Africa 69
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.956
Nazione #
US - Stati Uniti d'America 4.165
IT - Italia 875
SG - Singapore 846
CN - Cina 640
GB - Regno Unito 468
VN - Vietnam 381
BR - Brasile 328
SE - Svezia 315
HK - Hong Kong 284
DE - Germania 245
RU - Federazione Russa 112
UA - Ucraina 99
FR - Francia 94
FI - Finlandia 87
KR - Corea 83
NL - Olanda 75
IN - India 64
IE - Irlanda 47
CA - Canada 46
ID - Indonesia 43
TR - Turchia 41
BD - Bangladesh 37
LT - Lituania 34
BE - Belgio 32
BG - Bulgaria 31
MX - Messico 31
AR - Argentina 30
AU - Australia 24
PL - Polonia 22
IQ - Iraq 21
ZA - Sudafrica 21
CZ - Repubblica Ceca 20
JP - Giappone 19
ES - Italia 17
PK - Pakistan 15
MY - Malesia 12
CO - Colombia 11
EC - Ecuador 11
SA - Arabia Saudita 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
TW - Taiwan 10
CL - Cile 9
EG - Egitto 8
JO - Giordania 8
KE - Kenya 8
AT - Austria 7
CH - Svizzera 7
NO - Norvegia 7
UZ - Uzbekistan 7
MA - Marocco 6
PY - Paraguay 6
RS - Serbia 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
IL - Israele 4
IR - Iran 4
NG - Nigeria 4
PE - Perù 4
AZ - Azerbaigian 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MD - Moldavia 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
Totale 9.948
Città #
Singapore 524
Ashburn 503
Santa Clara 437
Fairfield 316
Hong Kong 279
Chandler 248
Southend 248
Woodbridge 213
San Jose 207
Hefei 179
Ann Arbor 148
Nyköping 139
Modena 138
Houston 131
Wilmington 131
Ho Chi Minh City 129
Seattle 123
Los Angeles 110
Beijing 109
Jacksonville 108
London 101
New York 93
Dearborn 90
Cambridge 79
Hanoi 78
Seoul 73
Council Bluffs 63
The Dalles 62
Helsinki 58
Milan 58
Chicago 51
Shanghai 43
Rome 41
Bologna 39
Moscow 37
São Paulo 37
Dublin 34
San Diego 34
Munich 33
Jakarta 32
Sofia 30
Fremont 28
Princeton 28
Lauterbourg 27
Brussels 23
Da Nang 23
Enschede 20
Orem 20
Salt Lake City 20
Buffalo 19
Phoenix 19
Eugene 18
Izmir 18
Dallas 17
Denver 17
Reggio Emilia 17
Haiphong 16
Chennai 15
Florence 15
Frankfurt am Main 15
Stockholm 15
Toronto 15
Brno 14
Johannesburg 14
Tokyo 14
Amsterdam 13
Elk Grove Village 13
Montreal 13
Warsaw 13
Redwood City 12
Rio de Janeiro 12
Bremen 11
Brooklyn 11
Columbus 11
Mexico City 11
Atlanta 10
Dong Ket 10
Parma 10
Poplar 10
Biên Hòa 9
Dhaka 9
Fuzhou 9
Grafing 9
Naples 9
Southwark 9
Bari 8
Belo Horizonte 8
Boston 8
Guarulhos 8
Kent 8
Mumbai 8
Turin 8
Amman 7
Basingstoke 7
Des Moines 7
Hải Dương 7
Jinan 7
Kunming 7
New Delhi 7
Paris 7
Totale 6.359
Nome #
IL FATTORE DI TRASCRIZIONE MEF2C AI CROCEVIA TRA PROLIFERAZIONE, SVILUPPO E DIFFERENZIAMENTO MUSCOLARE 697
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 468
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 428
NF-YA splice variants have different roles on muscle differentiation 403
Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition 386
NF-Y splice variants differentially affect skeletal myogenesis 383
Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells 380
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 345
Alternative splicing of transcription factors genes in muscle physiology and pathology 340
A novel complex regulates cardiac actin gene expression through interaction of Emb, a class VI POU domain protein, MEF2D, and the histone transacetylase p300 337
PROLINE ISOMERASE PIN1 REPRESSES TERMINAL DIFFERENTIATION AND MYOCYTE ENHANCER FACTOR 2C FUNCTION IN SKELETAL MUSCLE CELLS 328
The in vivo form of the murine class VIPOU protein Emb is larger than that encoded by previously described transcripts 316
A POTENTIAL ROLE OF MEF2C IN THE MYOGENIC PROGRESSION BESIDE TERMINAL DIFFERENTIATION 304
Proline Isomerase Pin1 represses terminal differentiation and Myocyte Enhancer Factor 2C function in Skeletal Muscle Cells 291
Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb. Ganassi M, Badodi S, Polacchini A, Baruffaldi F, Battini R, Hughes SM, Hinits Y, Molinari S. Biochim Biophys Acta. 2014 Jul;1839(7):559-70. doi: 10.1016/j.bbagrm.2014.05.003. Epub 2014 May 17. 284
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 278
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 274
Regulation of Mef2c activity by alternative splicing in zebrafish muscle development 266
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 257
PIN1: a putative molecular target to protect skeletal muscle against age-related muscle loss 254
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 210
Induction of Calbindin-D28K by 1,25-dihydroxyvitamin D3 in cultured chicken intestinal cells 188
Metabolome in Tibialis and Soleus Muscles in Wild-Type and Pin1 Knockout Mice through High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy 185
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 183
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 181
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression 173
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 167
Differential response of embryonic and fetal myoblasts to TGF-beta. A possible regulatory mechanism of skeletal histogenesis 158
Absence of mef2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle 157
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 157
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 147
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 139
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 135
Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor 132
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 116
The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4 107
Phosphorylation-dependent binding of MEF2 to the A/T rich element in the muscle creatine kinase enhancer correlates with lack of expression in embryonic mammalian muscle 88
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 78
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 73
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 65
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 61
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 60
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 46
Totale 10.025
Categoria #
all - tutte 33.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 114 47 48
2021/2022674 61 50 48 46 21 47 38 36 82 47 137 61
2022/2023821 94 107 57 92 59 103 31 76 81 25 45 51
2023/2024735 31 47 74 54 113 70 103 51 14 22 76 80
2024/20251.986 73 35 110 139 322 299 198 128 210 93 171 208
2025/20263.670 267 142 260 488 648 336 547 234 380 368 0 0
Totale 10.025